Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT06132828 · RECRUITING
Trial details
- NCT number
- NCT06132828
- Sponsor
- Zhejiang Doer Biologics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2027-07-30
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.